Gang YuanManaging Attorney
Mr. Gang Yuan is the managing attorney at our New York Office. He is a seasoned attorney focusing on corporate and business law, especially cross border transactions. He has practiced as a senior lawyer (partner and senior counsel) at leading US and UK law firms (Dewey & LeBoeuf LLP, Weil Gotshal & Manges LLP, Freshfields Bruckhaus Deringer LLP and Miller, Canfield, Paddock and Stone) for more than 10 years.
Mr. Yuan’s practice areas include Mergers & Acquisitions, IPOs, Private Equity, Joint Venture and Disputes Resolutions. For Chinese outbound transactions, Mr. Yuan acts for Chinese investors, including large state-owned companies, public companies and large private companies, for their investments around the world, mainly in the US, Canada, Europe, Central Asia, Southeast Asia and South American countries. For inbound investment to China, Mr. Yuan has advised a large number of multinational corporations in connection with their M&A activities and joint venture transactions. His experience includes representing one of the largest private equity firms to acquire a 20% interest in a state-owned enterprise in Shanghai, a major telecommunication company in its joint venture with the largest state-owned financial institution in Shanghai, a Chinese auto manufacturer to acquire a Korean auto company. Mr. Yuan was also involved in many investment related disputes and litigations, especially those disputes by Chinese companies for their investments in the US.
JD, University of Iowa, 2002
Master of Law, Peking University, 1996
- Dewey & LeBoeuf LLP
- Weil Gotshal & Manges LLP
- Freshfields Bruckhaus Deringer LLP
- Miller, Canfield, Paddock and Stone
- A Chinese policy bank’s financing for a gas-methanol project in Louisiana, deal amount $260 million for phase I;
- A large Chinese private company’s real estate development project in New York, including joint venture due diligence, transaction documents;
- A leading domestic education institute to acquire a private school at east coast of the US;
- A Chinese pubic company’s investment in the US healthcare sector, including acquisition of a medical lab in Virginia;
- A leading Chinese travel agency’s investment in the US；
- Several domestic funds’ investment in an agricultural plant in the State of Kentucky;
- A domestic fund affiliated with a Chinese public company, its acquisition of a farm with organic products at the upper state of the State of New York；
- A leading biopharma company’s investment to a bio-tech company in the State of Michigan;
- Several Chinese real estate development companies’ investment in New York and New Jersey commercial real properties, including due diligence, transaction structure and transaction documentation etc.;
- A Chinese private equity fund’s investment in commercial property in Manhattan;
- A large Chinese private company’s acquisition of a commercial plaza in the State of Hawaii; and
- A leading Chinese public company’s acquisition of a US entity under Section 363 of the US Bankruptcy Code.
- CNODC（CNPC’s wholly owned subsidiary）to acquire PetroKazakhstan Inc., deal amount $4.2 billion;
- CNOOC International Ltd. (wholly owned subsidiary of CNOOC Ltd.) to acquire 45% interest in AKPO deep sea blocks in Nigeria, deal amount $2.7 billion;
- CNODC’s acquisition of MMG, the largest privately owned oil & gas company in Kazakhstan, deal amount $2.3 billion;
- CNODC’s joint acquisition with ONGC of a Canadian company’s oil & gas assets in Syria, deal amount 484 million EUR;
- CNODC’s sale of 33% interest in its owned Kazakhstan subsidiary to KMG, deal amount $1,347 billion;
- A Chinese oil & gas company’s Russia-China gas pipeline project;
- A Chinese oil & gas company’s attempted acquisition of an international oil & gas company with assets in Russia；
- A Chinese oil & gas company’s attempted acquisition of a Canadian oil & gas company with assets in Africa;
- A Chinese company’s investment in US Agriculture sector; and
- A Chinese real estate development company’s development and acquisition in the US.